Issue navigation
Volume 27, Issue 4, April 2025
Editorials
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future?
EP Europace, Volume 27, Issue 4, April 2025, euaf063, https://doi.org/10.1093/europace/euaf063
A new basket player on the court: pulsed field ablation with a balloon-in-basket system for atrial fibrillation
EP Europace, Volume 27, Issue 4, April 2025, euaf065, https://doi.org/10.1093/europace/euaf065
Towards personalized therapy for atrial fibrillation: the rhythmic climbing of dronedarone
EP Europace, Volume 27, Issue 4, April 2025, euaf079, https://doi.org/10.1093/europace/euaf079
EHRA Documents
Epicardial ventricular arrhythmia ablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society
EP Europace, Volume 27, Issue 4, April 2025, euaf055, https://doi.org/10.1093/europace/euaf055
European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society
EP Europace, Volume 27, Issue 4, April 2025, euaf050, https://doi.org/10.1093/europace/euaf050
The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
EP Europace, Volume 27, Issue 4, April 2025, euaf067, https://doi.org/10.1093/europace/euaf067
Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society
EP Europace, Volume 27, Issue 4, April 2025, euae214, https://doi.org/10.1093/europace/euae214
Clinical Research
Baseline and 10-year change in the number of ideal cardiovascular health metrics and sudden cardiac death in the community
EP Europace, Volume 27, Issue 4, April 2025, euaf046, https://doi.org/10.1093/europace/euaf046
Identifying extra pulmonary vein targets for persistent atrial fibrillation ablation: bridging advanced and conventional mapping techniques
EP Europace, Volume 27, Issue 4, April 2025, euaf048, https://doi.org/10.1093/europace/euaf048
External validation of a machine learning-based classification algorithm for ambulatory heart rhythm diagnostics in pericardioversion atrial fibrillation patients using smartphone photoplethysmography: the SMARTBEATS-ALGO study
EP Europace, Volume 27, Issue 4, April 2025, euaf031, https://doi.org/10.1093/europace/euaf031
Socio-economic position and sudden cardiac death: a Danish nationwide study
EP Europace, Volume 27, Issue 4, April 2025, euaf001, https://doi.org/10.1093/europace/euaf001
Tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy
EP Europace, Volume 27, Issue 4, April 2025, euaf043, https://doi.org/10.1093/europace/euaf043
Clinical profile and outcomes among patients with cardiac implantable electronic device presenting as isolated pocket infection, pocket-related infective endocarditis, or lead-related infective endocarditis
EP Europace, Volume 27, Issue 4, April 2025, euaf053, https://doi.org/10.1093/europace/euaf053
Characterization of ventricular tachycardia ablation in end-stage heart failure patients with left ventricular assist device (CHANNELED registry)
EP Europace, Volume 27, Issue 4, April 2025, euaf054, https://doi.org/10.1093/europace/euaf054
Late arrhythmic burden in patients with left bundle branch block after TAVR with the Evolut valve
EP Europace, Volume 27, Issue 4, April 2025, euaf057, https://doi.org/10.1093/europace/euaf057
Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial
EP Europace, Volume 27, Issue 4, April 2025, euaf064, https://doi.org/10.1093/europace/euaf064
Sensing and detection performance of the novel, small-diameter OmniaSecure defibrillation lead: in-depth analysis from the LEADR trial
EP Europace, Volume 27, Issue 4, April 2025, euaf062, https://doi.org/10.1093/europace/euaf062
Ablation characteristics associated with steam pops in ablation index-guided radiofrequency ablation of atrial fibrillation
EP Europace, Volume 27, Issue 4, April 2025, euaf084, https://doi.org/10.1093/europace/euaf084
Dronedarone provides effective early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria
EP Europace, Volume 27, Issue 4, April 2025, euaf080, https://doi.org/10.1093/europace/euaf080
Translational Research
Mitochondrial damage mediates STING activation driving obesity-mediated atrial fibrillation
EP Europace, Volume 27, Issue 4, April 2025, euaf081, https://doi.org/10.1093/europace/euaf081
EHRA Surveys
Lifestyle and risk factor modification in atrial fibrillation: a European Heart Rhythm Association survey
EP Europace, Volume 27, Issue 4, April 2025, euaf075, https://doi.org/10.1093/europace/euaf075
Research Letters
Feasibility of a 90-watt, 3-second radiofrequency application for superior vena cava isolation during atrial fibrillation ablation
EP Europace, Volume 27, Issue 4, April 2025, euaf056, https://doi.org/10.1093/europace/euaf056
Impact of the presence of sinus rhythm during cavotricuspid isthmus ablation for atrial flutter on the incidence of future new-onset atrial fibrillation: insights from an international multi-centre registry
EP Europace, Volume 27, Issue 4, April 2025, euaf039, https://doi.org/10.1093/europace/euaf039
Acute ischaemic stroke during high-power short-duration ablation for atrial fibrillation patients: a case series study
EP Europace, Volume 27, Issue 4, April 2025, euaf068, https://doi.org/10.1093/europace/euaf068
Letters to the Editor
Carotid sinus massage in clinical practice
EP Europace, Volume 27, Issue 4, April 2025, euaf058, https://doi.org/10.1093/europace/euaf058
MicroPort CRM considerations on Vega pacing lead performance
EP Europace, Volume 27, Issue 4, April 2025, euaf060, https://doi.org/10.1093/europace/euaf060
Correction
Correction to: Feasibility of a 90-watt, 3-second radiofrequency application for superior vena cava isolation during atrial fibrillation ablation
EP Europace, Volume 27, Issue 4, April 2025, euaf078, https://doi.org/10.1093/europace/euaf078
